QSAR studies of a number of triazole antifungal alcohols

• Authors: Alicja Nowaczyk , Bożena Modzelewska-Banachiewicz
• Languages of publication: EN

Abstracts

EN

The activity of fungicide agents containing a quinazolinone ring was described using the quantitative structure-activity relationship (QSAR) model by applying it to data taken from literature. The title compounds exhibit two important types of activity against certain fungal pathogens, i.e. activity against yeast and activity against filamentous fungi. A correlation between both antifungal activities (e.g. FA(yst) and FA(ff)) and physicochemical parameters such as the logarithm of the n-octanol/water partition coefficient (log P), the polarizability (P), the global minimum energy (TE), the energy difference between the frontier molecular orbital (DELH) and the molar refractivity (MR), was established using multiple linear regression. The molecular descriptors of the antifungal agents were obtained by quantum chemical calculations combined with molecular modeling calculations. Statistical analysis shows that the antifungal activity depends mainly on the calculated partition coefficients, log P, of the compounds. Bi-parametric models reveal that antifungal activity relates linearly to log P and P. [...]

Keywords

EN

QSAR; Quinazolinone derivatives; Antifungal agent

• Publisher: De Gruyter Open
• Journal: Open Chemistry
• Year: 2010
• Volume: 8
• Issue: 2
• Pages: 440-447

Dates

published

1 - 4 - 2010

online

23 - 3 - 2010

Contributors

author

Alicja Nowaczyk

• Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-094, Bydgoszcz, Poland

author

Bożena Modzelewska-Banachiewicz

• Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-094, Bydgoszcz, Poland

References

• [1] D. J. Sheehan et al., Clin. Microbiol. Rev. 12(1), 40 (1999)
• [2] J. Wheat, Clin. Microbiol. Rev. 8(1), 146 (1995)
• [3] A. Chakrabarti, Microbiology 51(5), 16 (2005)
• [4] M.A. Hossain et al., Exp. Opin. Invest. Drugs 10, 1501 (2001) http://dx.doi.org/10.1517/13543784.10.8.1501[Crossref]
• [5] W.E. Trick et al., Clin. Infect. Dis. 35, 627 (2002) http://dx.doi.org/10.1086/342300[Crossref]
• [6] L.O. Sánchez-Vargas et al., Revista Iberoamericana de Micología 22, 83 (2005) http://dx.doi.org/10.1016/S1130-1406(05)70014-0[Crossref]
• [7] M.M. McNeil et al., Clin. Infect. Dis. 33, 641 (2001) http://dx.doi.org/10.1086/322606[Crossref]
• [8] S. Shoham et al., Br. J. Hematol. 129, 569 (2005) http://dx.doi.org/10.1111/j.1365-2141.2005.05397.x[Crossref]
• [9] M. Ruhnke et al., Eur. J. Med. Res. 7(5), 227 (2002)
• [10] M.D. Richardson, B. Jones, Therapeutic guidelines in systemic fungal infections (Remedica, London, 2006)
• [11] W.E. Dismukes, Clin. Infect. Dis. 30, 653 (2000) http://dx.doi.org/10.1086/313748[Crossref]
• [12] H.A. Gallis et al., Ref. Infect. Dis. 12, 308 (1990) [Crossref]
• [13] M.S. Espuelas et al., J Antimicrob Chemother 52, 419 (2003) http://dx.doi.org/10.1093/jac/dkg351[Crossref]
• [14] J.R. Wingard et al., B. B. Marrow Transplant. 10, 73 (2004) http://dx.doi.org/10.1016/j.bbmt.2003.09.014[Crossref]
• [15] S.M. Grant et al., Drugs 37, 310 (1989) http://dx.doi.org/10.2165/00003495-198937030-00003[Crossref]
• [16] A. Plettenberg et al., Mycoses 42, 269 (1999) http://dx.doi.org/10.1046/j.1439-0507.1999.00452.x[Crossref]
• [17] B.E. De Pauw, Int. J. Antimicrob. Agents 16, 147 (2000) http://dx.doi.org/10.1016/S0924-8579(00)00221-1[Crossref]
• [18] L. Ostrosky-Zeichner et al., Clin. Infect. Dis. 37, 415 (2003) http://dx.doi.org/10.1086/376634[Crossref]
• [19] S.P. Gupta, Chem. Rev. 94(6), 1507 (1994) http://dx.doi.org/10.1021/cr00030a003[Crossref]
• [20] E. Casabán-Ros et al., Quant. Struct.-Act. Relat. 18, 35 (1999) http://dx.doi.org/10.1002/(SICI)1521-3838(199901)18:1<35::AID-QSAR35>3.0.CO;2-Q[Crossref]
• [21] A.K. Ghose et al., Drug Discovery Today: Disease Models 11(23/24), 1107 (2006) [Crossref]
• [22] C. Hansch, et al., J. Med. Chem. 14(8), 653 (1971) http://dx.doi.org/10.1021/jm00290a001[Crossref]
• [23] H. González-Díaz et al., Bioorg. Med. Chem. 14, 973 (2006) http://dx.doi.org/10.1016/j.bmc.2005.09.014[Crossref]
• [24] V.M. Gokhale et al., Bioorg. Med. Chem. 8, 2487 (2000) http://dx.doi.org/10.1016/S0968-0896(00)00178-4[Crossref]
• [25] R.C. Lemoine et al., Bioorg. Med. Chem. Lett. 14(20), 5127 (2004) http://dx.doi.org/10.1016/j.bmcl.2004.07.070[Crossref]
• [26] F. King, Progress in Medicinal Chemistry Vol. 40 (Elsevier, Amsterdam 2002)
• [27] S.B. Mhaske et al., Tetrahedron 62, 9787 (2006) http://dx.doi.org/10.1016/j.tet.2006.07.098[Crossref]
• [28] J.L. Miller et al., Antimicrob. Agents Chemother. 48(2), 384 (2004) http://dx.doi.org/10.1128/AAC.48.2.384-387.2004[Crossref]
• [29] G. Ouyang et al., Molecules 11, 383 (2006) http://dx.doi.org/10.3390/11060383[Crossref]
• [30] L. Xue et al., Comb. Chem. High Throughput Screen 3, 363 (2000) [Crossref]
• [31] J. Bartroli et al., J Med Chem 41(11), 1869 (1998) http://dx.doi.org/10.1021/jm9707277[Crossref]
• [32] L.M. Podust et al., Proc. Natl. Acad. Sci. U. S. A. 98(6), 3068 (2001) http://dx.doi.org/10.1073/pnas.061562898[Crossref]
• [33] A. Macchiarulo et al., Bioorg. Med. Chem. 10, 3415 (2002) http://dx.doi.org/10.1016/S0968-0896(02)00263-8[Crossref]
• [34] R. Sabet et al., Research in Pharmaceutical Sciences 2(2), 103 (2009)
• [35] A. Kumar et al., Bioorganic & Medicinal Chemistry Letters 16(9), 2484 (2006) http://dx.doi.org/10.1016/j.bmcl.2006.01.080[Crossref]
• [36] P. Sharma et al., European Journal of Medicinal Chemistry 41(7), 833 (2006) http://dx.doi.org/10.1016/j.ejmech.2006.03.022[Crossref]
• [37] N. Zanatta et al., Bioorganic & medicinal chemistry 15(5), 1947 (2007) http://dx.doi.org/10.1016/j.bmc.2007.01.003[Crossref]
• [38] Q.L. Wei et al., Bioorganic & medicinal chemistry 14(21), 7146 (2006) http://dx.doi.org/10.1016/j.bmc.2006.06.065[Crossref]
• [39] P. Vasanthanathan et al., Biological & Pharmaceutical Bulletin 29(6), 1262 (2006) http://dx.doi.org/10.1248/bpb.29.1262[Crossref]
• [40] B. Kocsis et al., European Journal of Medicinal Chemistry 44(5), 1823 (2009) http://dx.doi.org/10.1016/j.ejmech.2008.10.038[Crossref]
• [41] R. Todeschini, V. Consonni, Molecular Descriptors for Chemoinformatics (Wiley-VCH, Weinheim, 2009) http://dx.doi.org/10.1002/9783527628766[Crossref]
• [42] Z. Medven et al., Journal of Chemometrics 10(2), 135 (1996) http://dx.doi.org/10.1002/(SICI)1099-128X(199603)10:2<135::AID-CEM413>3.0.CO;2-V[Crossref]
• [43] J. M. Luco et al., J. Chem. Inf. Comput. Sci 37(2), 392 (1997) [Crossref]
• [44] P. Gramatica, QSAR & Comb. Sci. 26(5), 694 (2007) http://dx.doi.org/10.1002/qsar.200610151[Crossref]
• [45] E. Deconinck et al., J. Pharmaceut. Biomed. 43(1), 119 (2007) http://dx.doi.org/10.1016/j.jpba.2006.06.022[Crossref]
• [46] A. Tropsha et al., QSAR & Comb. Sci. 22(1), 69 (2003) http://dx.doi.org/10.1002/qsar.200390007[Crossref]
• [47] D.M. Hawkins, J Chem Inf Comput Sci 44(1), 1 (2004) [Crossref]
• [48] H. Kubinyi, Drug Discovery Today 2(11), 457 (1997) http://dx.doi.org/10.1016/S1359-6446(97)01079-9[Crossref]
• [49] H. Kubinyi, Drug Discovery Today 2(12), 538 (1997) http://dx.doi.org/10.1016/S1359-6446(97)01084-2[Crossref]
• [50] R. Kiralj et al., Journal of the Brazilian Chemical Society 20, 770 (2009) http://dx.doi.org/10.1590/S0103-50532009000400021[Crossref]
• [51] S. Wold, L. Eriksson, Chemometric methods in molecular design (VCH, Weinheim, 1995)
• [52] E. Papa et al., J. Chem. Inf. Model 45(5), 1256 (2005) http://dx.doi.org/10.1021/ci050212l[Crossref]
• [53] G. Aperis et al., Exp. Opin. Inv. Drugs 15(6), 579 (2006) http://dx.doi.org/10.1517/13543784.15.6.579[Crossref]
• [54] J. Capilla et al., Antimicrob. Agents Chemother. 45(9), 2635 (2001) http://dx.doi.org/10.1128/AAC.45.9.2635-2637.2001[Crossref]
• [55] S.H. Alves et al., Mycoses 49, 220 (2006) http://dx.doi.org/10.1111/j.1439-0507.2006.01226.x[Crossref]
• [56] A.C. Pasqualotto et al., J. Antimicrob. Chemother. 61(Supplement 1), i19 (2008) http://dx.doi.org/10.1093/jac/dkm428[Crossref]

Identifiers

DOI

10.2478/s11532-009-0143-7